Karyopharm Therapeutics | KPTI - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.12B 183M 2025-09
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.28B 252M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 5.38B 1.12B 2025-12
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Incyte USD 1.63B 1.46B 2025-12
J&J USD 11.99B 2.37B 2025-12
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
MacroGenics USD 4.79M 1.15M 2025-12
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Novartis USD 4.46B 99M 2025-12
Novartis USD 4.46B 99M 2025-12
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Takeda JPY 467.59B 28.61B 2025-12
Tectonic Therapeutic USD 1.09M 392K 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Xencor USD 10.83M 1.75M 2025-12